An agency of the European Union
Frequent searches:
An outbreak of Salmonella Stanley ST2045 is ongoing in the EU/EEA, with a total of 106 confirmed cases having been reported by 13 EU/EEA countries (77) and the United Kingdom (29) between November 2025 and June 2026.
Multi-country outbreak of Salmonella Stanley ST2045 infections linked to consumption of flavoured noodle products
English (795.1 KB - PDF)
Between 15 and 21 June 2026, the EUHTF conducted a fact-finding mission to the DRC and Uganda to assess airport exit screening procedures in the context of the ongoing outbreak of Ebola disease caused by the Bundibugyo virus.
Fact-finding mission on airport exit screening
English (1.61 MB - PDF)
Preliminary data from the main collection of the survey of carbapenem-resistant Enterobacterales 2025 (CRE25 survey) indicates a considerable change in the carbapenemase gene distribution in carbapenem-resistant or carbapenem-susceptible, increased exposure (carbapenem-R/I) Klebsiella pneumoniae species complex (SC).
Changing carbapenemase distribution in Klebsiella pneumoniae and Escherichia coli in the EU/EEA – preliminary results from the main collection of the CRE25 survey
English (355 KB - PDF)
Between January and May 2026, 109 confirmed cases of Salmonella Bovismorbificans ST377 were reported from 10 European Union/European Economic Area (EU/EEA) countries (Austria, Belgium, Czechia, Denmark, Finland, Germany, Ireland, Luxembourg, Spain and the Netherlands) and the United Kingdom.
Multi-country outbreak of Salmonella Bovismorbificans ST377 infections linked to the consumption of alfalfa sprouted seeds
English (1.99 MB - PDF)
This report presents the findings and recommendations of the first assessment conducted in Cyprus. This involved a desk review of relevant documents, followed by a five-day country visit that took place between 1and 5 December 2025.
ECDC Public Health Emergency Preparedness Assessment for Cyprus 2025.pdf
English (1.9 MB - PDF)
This rapid systematic review aimed to identify and assess the strength and consistency of associations between clinical risk factors and severe RSV outcomes in adults.
Rapid systematic review of clinical risk factors for severe Respiratory Syncytial Virus infection in adults resulting in hospitalisation, intensive care unit admission or death
English (2.01 MB - PDF)
Several clusters of genetically and epidemiologically linked cases predominantly affecting gay, bisexual and other men who have sex with men have been detected in four EU countries during the past six months. Cases have also been reported in Norway among individuals practicing martial arts, in 2025 and 2026.
Clusters of dermatophilosis in five EU/EEA countries in 2025–2026
English (317.19 KB - PDF)
This assessment presents an overview and critical appraisal of the available modelling evidence to inform the scale and potential spread of Bundibugyo virus (BDBV) in the context of the ongoing Ebola disease outbreak in the Democratic Republic of the Congo (DRC) and Uganda.
Overview of available modelling evidence to inform the scale and potential spread of Bundibugyo virus in the current Ebola disease outbreak
English (318.16 KB - PDF)
This report presents the findings and recommendations of the first assessment conducted in Lithuania. This involved a desk review of relevant documents, followed by a five-day country visit that took place between 15 September and 19 September 2025.
ECDC Public Health Emergency Preparedness Assessment for Lithuania, 2025
English (3.75 MB - PDF)
In this report, we present estimates of the probability of importation of Ebola disease caused by Bundibugyo virus (BDBV), into EU/EEA countries for the period 11–25 June 2026 under different assumptions of travel volumes from the areas where most cases were reported from.
Estimation of the importation risk of Bundibugyo virus into the EU/EEA in June 2026
English (515.05 KB - PDF)
This document aims to provide guidance for public health, healthcare providers and infection prevention and control (IPC) professionals in the EU/EEA regarding IPC measures should there be individuals meeting the criteria for ‘person under investigation’ (PUI).
Rapid ECDC advice on infection prevention and control measures for Ebola disease in EU/EEA healthcare settings
English (382.47 KB - PDF)
The ongoing outbreak of Ebola disease caused by Bundibugyo virus in the Democratic Republic of the Congo (DRC) and Uganda reported in May 2026 has prompted ECDC to review its operational guidance relevant to air travel. In this context, updated guidance is needed to support preparedness and public health action if a case is identified during or after a flight.
Risk assessment guidelines for infectious diseases transmitted on aircraft (RAGIDA) – Ebola disease update
English (373.82 KB - PDF)
The European Centre for Disease Prevention and Control (ECDC), the European Commission’s Directorate-General for Health and Food Safety (DG SANTE) and the European Food Safety Authority (EFSA) conducted a country visit to Serbia from 24 to 28 February 2025.
ECDC/EC/EFSA country visit to Serbia to advance One Health responses against antimicrobial resistance
English (1.22 MB - PDF)
On 15 May 2026, Africa CDC reported an outbreak of Ebola disease in Ituri Province, DRC. Laboratory analysis at Institut National de Recherche Biomedicale of DRC identified Bundibugyo virus (BDBV). BDBV disease is a rare disease but can cause outbreaks with high case fatality rates. Considering the available information, complicated context and the uncertainties on the epidemiological information WHO declared a Public Health Emergency of International Concern on 17 May 2026. Africa CDC declared a Public Health Emergency of Continental Security on 18 May 2026.
Ebola disease outbreak caused by Bundibugyo virus – Democratic Republic of the Congo and Uganda
English (315.32 KB - PDF)
This document aims to provide advice on infection prevention and control (IPC) measures for healthcare facilities providing care to patients with suspected or confirmed ANDV disease.
Rapid scientific advice on infection, prevention and control measures for patients in healthcare settings with Andes virus (ANDV) disease
English (333.06 KB - PDF)
This document provides advice for public health professionals in the EU/EEA managing individuals potentially exposed to Andes virus infection.
Rapid Scientific Advice on the management of passengers - In the context of the Andes virus outbreak on the cruise ship MV Hondius
English (471.89 KB - PDF)
As of 6 May 2026, seven cases have been reported in a hantavirus-associated cluster of illness on a cruise ship, including three deaths, one critically ill, two symptomatic and one with unknown status.
Hantavirus-associated cluster of illness on a cruise ship: ECDC assessment and recommendations
English (403.61 KB - PDF)
ECDC cooperates with countries under the EU enlargement policy to improve their infectious disease prevention and control systems and public health workforce and prepare them for their future participation in ECDC’s work.
ECDC review of communicable disease surveillance in Ukraine
English (324.85 KB - PDF)
This document is an update of the rapid scientific advice published in June 2025. It contains recommendations on the EURL(s) for public health to be implemented under the 2026 EU4Health Work Programme.
Rapid ECDC advice on the designation of future European Reference Laboratories for public health
English (290.76 KB - PDF)
From 19 December 2025 to 13 February 2026, six EU countries and the United Kingdom reported infants with gastrointestinal symptoms following the consumption of contaminated infant formula.
Multi-country foodborne event caused by cereulide in infant formula products
English (454.91 KB - PDF)
ECDC conducted a technical visit to Kosovo in March 2025 to obtain additional information on the country’s national surveillance system.
Kosovo report on country visit to discuss surveillance communicable diseases
English (308.4 KB - PDF)
This report presents the findings and recommendations of the first assessment conducted in France.
Country report: ECDC Public Health Emergency Preparedness Assessment for France, 2025
English (1.72 MB - PDF)
ECDC conducted a technical visit to Türkiye in April 2025 to obtain a comprehensive overview of the country’s national surveillance system, including its operation and governance, its needs, vulnerabilities and strengths.
ECDC country visit to Türkiye to discuss surveillance of communicable diseases
English (330.21 KB - PDF)
Influenza vaccine coverage remains below the WHO-recommended threshold for risk groups in most EU/EEA countries, while COVID-19 vaccine coverage is declining across most countries.
Multi-model analysis to quantify the impact of vaccination on COVID-19 and influenza hospitalisation burden among older adults in the EU/EEA, 2024/25
English (879.12 KB - PDF)
This report presents the findings and recommendations of the second assessment in the three-year programme, conducted in Finland.
ECDC Public Health Emergency Preparedness Assessment for Finland, 2024
English (2.08 MB - PDF)